AMO Pharma raises $25 million in private equity financing AMO Pharma Small.

Related StoriesNew scientific trial on breast cancers may help deal with and control diseaseMoffitt Tumor Center study finds link between common gene mutations and tumor immune surveillanceUCSF-led researchers map out melanoma's genetic trajectoriesAMO Pharma also plans to initiate a clinical plan in fragile X syndrome with a second product candidate, AMO-01. According to the FRAXA Research Basis, fragile X syndrome is the most common inherited cause of autism and intellectual disabilities. AMO-01 is an inhibitor of the ras-extracellular signal-regulated kinase pathway .Marked improvement takes place with usage of an antibiotic and corticosteroid ointment, however the problem returns within times of ceasing treatment. Is certainly allergy to a lipbalm element likely? How must i proceed?

Aetna faces Medicare sanctions Wellness insurer Aetna announced Fri it will suspend ‘advertising to and enrollment of new people to its Medicare programs for the elderly due to sanctions imposed by the U.S. Government,’ Reuters reports. Wall structure Street Journal: The issues described by the Centers for Medicare and Medicaid Solutions involve ‘compliance problems related to drug-plan requirements.